HEADER TRANSFERASE 15-AUG-23 8Q77 TITLE STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; TITLE 2 CSNK2A2 GENE PRODUCT) IN COMPLEX WITH THE BISUBSTRATE INHIBITOR ARC- TITLE 3 780 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2 CASEIN KINASE 2 BISUBSTRATE INHIBITOR N-TERMINAL KEYWDS 2 SEGMENT LIGAND BINDING SITE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.WERNER,D.LINDENBLATT,K.NIEFIND REVDAT 1 06-DEC-23 8Q77 0 JRNL AUTH C.WERNER,D.LINDENBLATT,K.VIHT,A.URI,K.NIEFIND JRNL TITL DISCOVERY AND EXPLORATION OF PROTEIN KINASE CK2 BINDING JRNL TITL 2 SITES USING CK2ALPHA CYS336SER AS AN EXQUISITE JRNL TITL 3 CRYSTALLOGRAPHIC TOOL JRNL REF KINASES PHOSPHATASES 2023 JRNL DOI 10.3390/KINASESPHOSPHATASES1040018 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.HOCHSCHERF REMARK 1 TITL DIACRITIC BINDING OF AN INDENOINDOLE INHIBITOR BY CK2ALPHA REMARK 1 TITL 2 PARALOGS EXPLORED BY A RELIABLE PATH TO ATOMIC RESOLUTION REMARK 1 TITL 3 CK2ALPHA' STRUCTURES. REMARK 1 REF ACS OMEGA V. 4 5471 2019 REMARK 1 REFN ESSN 2470-1343 REMARK 1 PMID 31559376 REMARK 1 DOI 10.1016/J.FEBSLET.2006.06.031 REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 72.5 REMARK 3 NUMBER OF REFLECTIONS : 80283 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.120 REMARK 3 R VALUE (WORKING SET) : 0.120 REMARK 3 FREE R VALUE : 0.157 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.510 REMARK 3 FREE R VALUE TEST SET COUNT : 1214 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.2500 - 2.6100 0.99 11948 192 0.1393 0.1724 REMARK 3 2 2.6100 - 2.0700 0.85 10330 149 0.1136 0.1441 REMARK 3 3 2.0700 - 1.8100 0.91 11012 168 0.0948 0.1317 REMARK 3 4 1.8100 - 1.6400 0.92 11172 168 0.0922 0.1245 REMARK 3 5 1.6400 - 1.5300 0.93 11309 177 0.1030 0.1459 REMARK 3 6 1.5300 - 1.4400 0.92 11161 184 0.1155 0.1831 REMARK 3 7 1.4400 - 1.3600 0.67 8124 121 0.1473 0.2104 REMARK 3 8 1.3600 - 1.3100 0.27 3299 44 0.1881 0.2404 REMARK 3 9 1.3100 - 1.2550 0.06 714 11 0.2711 0.3820 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.086 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.915 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.023 3016 REMARK 3 ANGLE : 1.772 4058 REMARK 3 CHIRALITY : 0.142 408 REMARK 3 PLANARITY : 0.018 524 REMARK 3 DIHEDRAL : 18.298 1159 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8Q77 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292132718. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9677 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 80300 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.255 REMARK 200 RESOLUTION RANGE LOW (A) : 46.578 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 72.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.55900 REMARK 200 R SYM FOR SHELL (I) : 0.55900 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE CK2ALPHA' SOLUTION AFTER PROTEIN REMARK 280 PURIFICATION (5 MG/ML CK2ALPHA' IN 500 MM NACL, 25 MM TRIS/HCL, REMARK 280 PH 8.5) WAS MIXED IN 1:10 VOLUME RATIO WITH 10 MM SOLUTION OF REMARK 280 THE INHIBITOR MB002 IN DMSO. THIS SOLUTION WAS MIXED IN 2:1 REMARK 280 RATIO WITH RESERVOIR SOLUTION [900 MM LICL, 28 % (W/V) PEG 6000, REMARK 280 250 MM TRIS/HCL, PH 8.5] IN SITTING DROP PLATES (VAPOUR REMARK 280 DIFFUSION). THE CRYSTAL GROWTH WAS INDUCED BY MICROSEEDING. THE REMARK 280 CRYSTALS WERE OPTIMIZED BY MACROSEEDING AND PURGED TWICE WITH REMARK 280 RESERVOIR SOLUTION. THEN, ARC-780 WAS ADDED TO AN INITIAL REMARK 280 CONCENTRATION OF 1 MM BY ADDING 1 MIKROLITER OF A 10 MM ARC-780 REMARK 280 SOLUTION IN DMSO IN A 1:10 RATIO TO THE DROPLET. AFTER EXTENSIVE REMARK 280 INTIAL SOAKING, THE SALT CONCENTRATION WAS SUCCESSIVELY LOWERED REMARK 280 OVER A PERIOD OF 8 MONTHS WHILE IN PARALLEL THE CONCENTRATIONS REMARK 280 OF DMSO AND PEG 6000 WERE INCREASED. THIS WAS DONE BY GRADUALLY REMARK 280 REPLACING THE RESERVOIR AND THE DROPLET SOLUTION UNTIL ANY NACL REMARK 280 WAS REMOVED, THE LICL CONCENTRATION WAS REDUCED TO 50 MM, THE REMARK 280 PEG 6000 CONCENTRATION WAS INCREASED TO SATURATION AND A DMSO REMARK 280 CONTENT OF 30% WAS REACHED. MEANWHILE, THE ARC-780 LIGAND WAS REMARK 280 INCLUDED IN ANY DESALTING STEP REACHING SATURATION AFTER THE REMARK 280 FINAL DILUTION STEP. ALL STEPS WERE PERFORMED AT A TEMPERATURE REMARK 280 OF 293 K., VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL A 54 CB VAL A 54 CG1 -0.140 REMARK 500 LYS A 77 CB LYS A 77 CG -0.172 REMARK 500 TYR A 147 CE1 TYR A 147 CZ -0.084 REMARK 500 GLN A 276 CG GLN A 276 CD 0.158 REMARK 500 LYS A 280 CE LYS A 280 NZ 0.181 REMARK 500 GLU A 318 CD GLU A 318 OE1 -0.074 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 38 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 MET A 138 CG - SD - CE ANGL. DEV. = -12.2 DEGREES REMARK 500 TYR A 147 CB - CG - CD2 ANGL. DEV. = 4.1 DEGREES REMARK 500 ASP A 211 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 LEU A 219 CB - CG - CD1 ANGL. DEV. = 16.2 DEGREES REMARK 500 ASP A 265 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 PHE A 325 CB - CG - CD2 ANGL. DEV. = 4.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 157 43.87 -148.28 REMARK 500 ASP A 176 78.88 60.57 REMARK 500 ALA A 194 153.07 71.65 REMARK 500 MET A 209 36.79 -89.03 REMARK 500 MET A 209 56.68 -96.00 REMARK 500 HIS A 235 73.32 -109.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 245 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 8Q77 A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 8Q77 MET A -13 UNP P19784 INITIATING METHIONINE SEQADV 8Q77 GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 8Q77 SER A -11 UNP P19784 EXPRESSION TAG SEQADV 8Q77 SER A -10 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 8Q77 HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 8Q77 SER A -3 UNP P19784 EXPRESSION TAG SEQADV 8Q77 GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 8Q77 ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 8Q77 PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 8Q77 SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION SEQRES 1 A 364 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 364 PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG VAL SEQRES 3 A 364 TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR TRP SEQRES 4 A 364 ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN ASP SEQRES 5 A 364 ASP TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SEQRES 6 A 364 SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU SEQRES 7 A 364 ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS SEQRES 8 A 364 LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU ARG SEQRES 9 A 364 GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL LYS SEQRES 10 A 364 ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU TYR SEQRES 11 A 364 ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE LEU SEQRES 12 A 364 THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU LEU SEQRES 13 A 364 LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET HIS SEQRES 14 A 364 ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLN SEQRES 15 A 364 GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU SEQRES 16 A 364 PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL ALA SEQRES 17 A 364 SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR SEQRES 18 A 364 GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY SEQRES 19 A 364 CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO PHE SEQRES 20 A 364 PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG ILE SEQRES 21 A 364 ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR LEU SEQRES 22 A 364 LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN ASP SEQRES 23 A 364 ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN PHE SEQRES 24 A 364 ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU ALA SEQRES 25 A 364 LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SEQRES 26 A 364 GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO TYR SEQRES 27 A 364 PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER ALA SEQRES 28 A 364 ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA ARG HET LN3 A 401 110 HET LN3 A 402 110 HET EDO A 403 10 HET EDO A 404 10 HET EDO A 405 10 HET EDO A 406 10 HET EDO A 407 10 HET EDO A 408 10 HET CL A 409 1 HETNAM LN3 (2~{S})-2-[[(2~{S})-2-[[(2~{S})-2-[12-[[4-[[5-(4- HETNAM 2 LN3 CARBOXYPHENYL)-1,3-THIAZOL-2-YL]AMINO]-4- HETNAM 3 LN3 OXIDANYLIDENE-BUTANOYL]-(2-HYDROXY-2-OXOETHYL) HETNAM 4 LN3 AMINO]DODECANOYLAMINO]-4-OXIDANYL-4-OXIDANYLIDENE- HETNAM 5 LN3 BUTANOYL]AMINO]-4-OXIDANYL-4-OXIDANYLIDENE- HETNAM 6 LN3 BUTANOYL]AMINO]BUTANEDIOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 LN3 2(C40 H52 N6 O17 S) FORMUL 4 EDO 6(C2 H6 O2) FORMUL 10 CL CL 1- FORMUL 11 HOH *311(H2 O) HELIX 1 AA1 ALA A 10 GLU A 15 1 6 HELIX 2 AA2 SER A 21 ASP A 26 1 6 HELIX 3 AA3 TYR A 27 HIS A 30 5 4 HELIX 4 AA4 LYS A 75 LEU A 89 1 15 HELIX 5 AA5 ASP A 121 TYR A 126 1 6 HELIX 6 AA6 THR A 130 LYS A 151 1 22 HELIX 7 AA7 LYS A 159 HIS A 161 5 3 HELIX 8 AA8 SER A 195 LYS A 199 5 5 HELIX 9 AA9 GLY A 200 VAL A 205 1 6 HELIX 10 AB1 TYR A 212 ARG A 229 1 18 HELIX 11 AB2 ASP A 238 GLY A 251 1 14 HELIX 12 AB3 GLY A 251 HIS A 263 1 13 HELIX 13 AB4 ASP A 267 ILE A 273 5 7 HELIX 14 AB5 ARG A 281 ILE A 286 5 6 HELIX 15 AB6 ASN A 290 VAL A 294 5 5 HELIX 16 AB7 SER A 295 LEU A 306 1 12 HELIX 17 AB8 THR A 315 GLU A 321 1 7 HELIX 18 AB9 HIS A 322 TYR A 324 5 3 HELIX 19 AC1 PHE A 325 GLN A 334 1 10 SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ILE A 99 SHEET 4 AA1 6 ARG A 65 LEU A 71 -1 N LYS A 69 O LEU A 112 SHEET 5 AA1 6 SER A 52 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 ARG A 48 -1 N VAL A 43 O GLU A 56 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166 CISPEP 1 GLU A 231 PRO A 232 0 -12.17 CRYST1 46.603 47.919 51.031 66.59 89.67 88.16 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021458 -0.000689 0.000164 0.00000 SCALE2 0.000000 0.020879 -0.009040 0.00000 SCALE3 0.000000 0.000000 0.021354 0.00000